Cargando…

Mesenchymal Stem Cells and Inflammatory Cardiomyopathy: Cardiac Homing and Beyond

Under conventional heart failure therapy, inflammatory cardiomyopathy usually has a progressive course, merging for alternative interventional strategies. There is accumulating support for the application of cellular transplantation as a strategy to improve myocardial function. Mesenchymal stem cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van Linthout, S., Stamm, Ch., Schultheiss, H.-P., Tschöpe, C.
Formato:	Texto
Lenguaje:	English
Publicado:	SAGE-Hindawi Access to Research 2011
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3051267/ https://www.ncbi.nlm.nih.gov/pubmed/21403844 http://dx.doi.org/10.4061/2011/757154

Ejemplares similares

Cardiac Migration of Endogenous Mesenchymal Stromal Cells in Patients with Inflammatory Cardiomyopathy
por: Schmidt-Lucke, Caroline, et al.
Publicado: (2015)

Immunomodulatory Effects of Mesenchymal Stromal Cells Revisited in the Context of Inflammatory Cardiomyopathy
por: Miteva, Kapka, et al.
Publicado: (2013)

A Toolbox of Potential Immune-Related Therapies for Inflammatory Cardiomyopathy
por: Elsanhoury, Ahmed, et al.
Publicado: (2020)

Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis
por: Van Linthout, S., et al.
Publicado: (2011)

Reversible transition from a hypertrophic to a dilated cardiomyopathy
por: Spillmann, Frank, et al.
Publicado: (2015)

Mesenchymal stromal cells inhibit NLRP3 inflammasome activation in a model of Coxsackievirus B3-induced inflammatory cardiomyopathy
por: Miteva, Kapka, et al.
Publicado: (2018)

Mesenchymal Stromal Cells but Not Cardiac Fibroblasts Exert Beneficial Systemic Immunomodulatory Effects in Experimental Myocarditis
por: Savvatis, Konstantinos, et al.
Publicado: (2012)

Cardiac contractility modulation: mechanisms of action in heart failure with reduced ejection fraction and beyond
por: Tschöpe, Carsten, et al.
Publicado: (2018)

Targeting CD20+ B-lymphocytes in inflammatory dilated cardiomyopathy with rituximab improves clinical course: a case series
por: Tschöpe, Carsten, et al.
Publicado: (2019)

Impact of Syndecan-2-Selected Mesenchymal Stromal Cells on the Early Onset of Diabetic Cardiomyopathy in Diabetic db/db Mice
por: Pappritz, Kathleen, et al.
Publicado: (2021)

New Echocardiographic Findings Correlate with Intramyocardial Inflammation in Endomyocardial Biopsies of Patients with Acute Myocarditis and Inflammatory Cardiomyopathy
por: Escher, Felicitas, et al.
Publicado: (2013)

Mesenchymal Stromal Cells Modulate Monocytes Trafficking in Coxsackievirus B3‐Induced Myocarditis
por: Miteva, Kapka, et al.
Publicado: (2017)

New Insights in (Inter)Cellular Mechanisms by Heart Failure with Preserved Ejection Fraction
por: Tschöpe, Carsten, et al.
Publicado: (2014)

Viral myocarditis: a prime example for endomyocardial biopsy-guided diagnosis and therapy
por: Van Linthout, Sophie, et al.
Publicado: (2018)

Inflammation – Cause or Consequence of Heart Failure or Both?
por: Van Linthout, Sophie, et al.
Publicado: (2017)

Cardiac (myo)fibroblasts modulate the migration of monocyte subsets
por: Pappritz, Kathleen, et al.
Publicado: (2018)

Myocarditis and inflammatory cardiomyopathy: current evidence and future directions
por: Tschöpe, Carsten, et al.
Publicado: (2020)

Human Cardiac-Derived Adherent Proliferating Cells Reduce Murine Acute Coxsackievirus B3-Induced Myocarditis
por: Miteva, Kapka, et al.
Publicado: (2011)

Genomic expression profiling of human inflammatory cardiomyopathy (DCMi) suggests novel therapeutic targets
por: Wittchen, F., et al.
Publicado: (2006)

Gene Deletion of the Kinin Receptor B1 Attenuates Cardiac Inflammation and Fibrosis During the Development of Experimental Diabetic Cardiomyopathy
por: Westermann, Dirk, et al.
Publicado: (2009)

Activation, homing, and role of the mesenchymal stem cells in the inflammatory environment
por: Zachar, Lukáš, et al.
Publicado: (2016)

Modulation of the acute defence reaction by eplerenone prevents cardiac disease progression in viral myocarditis
por: Tschöpe, Carsten, et al.
Publicado: (2020)

SARS‐CoV‐2‐related myocarditis‐like syndromes Shakespeare's question: what's in a name?
por: Van Linthout, Sophie, et al.
Publicado: (2020)

Monocyte Chemotactic Protein-1 Promotes the Myocardial Homing of Mesenchymal Stem Cells in Dilated Cardiomyopathy
por: Guo, Jing, et al.
Publicado: (2013)

Mesenchymal Stem Cell Therapy in Diabetic Cardiomyopathy
por: da Silva, Jaqueline S., et al.
Publicado: (2022)

Sex- and age-related differences in the inflammatory properties of cardiac fibroblasts: impact on the cardiosplenic axis and cardiac fibrosis
por: Pappritz, Kathleen, et al.
Publicado: (2023)

Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy: An Expert Consensus Document
por: Ammirati, Enrico, et al.
Publicado: (2020)

Plasminogen activator inhibitor-1 reduces cardiac fibrosis and promotes M2 macrophage polarization in inflammatory cardiomyopathy
por: Baumeier, Christian, et al.
Publicado: (2021)

Clinical mesenchymal stem cell therapy in ischemic cardiomyopathy
por: Mazine, Amine, et al.
Publicado: (2021)

Mesenchymal Stem Cells Beyond Regenerative Medicine
por: Shammaa, Riam, et al.
Publicado: (2020)

High Perforin‐Positive Cardiac Cell Infiltration and Male Sex Predict Adverse Long‐Term Mortality in Patients With Inflammatory Cardiomyopathy
por: Escher, Felicitas, et al.
Publicado: (2017)

Epicardial Fat Expansion in Diabetic and Obese Patients With Heart Failure and Preserved Ejection Fraction—A Specific HFpEF Phenotype
por: Elsanhoury, Ahmed, et al.
Publicado: (2021)

Myeloid-Derived Suppressor Cells Restrain Natural Killer Cell Activity in Acute Coxsackievirus B3-Induced Myocarditis
por: Müller, Irene, et al.
Publicado: (2021)

Mesenchymal stem cell therapy for doxorubicin cardiomyopathy: hopes and fears
por: Ezquer, Fernando, et al.
Publicado: (2015)

Mesenchymal Stem Cells Migration Homing and Tracking
por: Sohni, Abhishek, et al.
Publicado: (2013)

Intramyocardial transplantation of cardiac mesenchymal stem cells reduces myocarditis in a model of chronic Chagas disease cardiomyopathy
por: Silva, Daniela Nascimento, et al.
Publicado: (2014)

Back to the Future: Moving Beyond “Mesenchymal Stem Cells”
por: Bianco, Paolo
Publicado: (2011)

Cardiac mesenchymal stromal cells are a source of adipocytes in arrhythmogenic cardiomyopathy
por: Sommariva, E., et al.
Publicado: (2016)

Intramuscular injection of human umbilical cord-derived mesenchymal stem cells improves cardiac function in dilated cardiomyopathy rats
por: Mao, Chenggang, et al.
Publicado: (2017)

Adipose-derived mesenchymal stem cells preserve cardiac function via ANT-1 in dilated cardiomyopathy hamster model
por: Mori, Daisuke, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_62pcc9gjrv35giedotu7dp1e9l